RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the independent presentation of new preclinical data at the 2026 American Association for ...
A new method of making cancer cells more visible to the immune system could improve how well immunotherapy works against a range of different tumors, potentially leading to more effective treatment ...
Palleon Pharmaceuticals today presented preclinical data and announced the initiation of a human clinical trial for E-688/HLX316, a first-in-class B7-H3 targeted sialidase, in an oral presentation at ...
Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases April 20, 2026 8:30 AM ...
New study uncovers triplex-mediated transcriptional activation driving tumor suppression in HCC Hepatocellular carcinoma (HCC ...
MG-ADL and QMG at 24 weeks, further increasing confidence in Phase 3 trial . Totality of efficacy and safety data re ...
UAB researchers discover that the immune system consistently targets the same region of mismatched HLA proteins after organ ...
Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results